Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal function

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2014-04, Vol.49 (4), p.589-591
Hauptverfasser:	Griffiths, C D, Ng, E S M, Kangarloo, S B, Williamson, T S, Chaudhry, M A, Booker, R, Duggan, P, Yue, P, Savoie, L, Brown, C, Cox-Kennett, N, Russell, J A, Daly, A, Storek, J
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/1904 631/92/436/1729 692/699/249/1529 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Cell Biology Dosage and administration Fludarabine Hematology Hematopoietic Stem Cell Transplantation - methods Humans Internal Medicine Kidney - metabolism Kidneys letter-to-the-editor Medical sciences Medicine Medicine & Public Health Metabolites Multivariate Analysis Physiological aspects Public Health Renal function Stem cell transplantation Stem Cells Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation Conditioning - methods Treatment Outcome Vidarabine - analogs & derivatives Vidarabine - blood Vidarabine - pharmacokinetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!